Drug profile · INN
insulin aspart
INSULIN ASPART INJECTION
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
insulin aspart (INSULIN ASPART INJECTION) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN insulin aspart
Brand INSULIN ASPART INJECTION
Route SUBCUTANEOUS
Formulation SOLUTION
ATC code A10AB05
Related patents
Search patents →Frequently asked questions
What is insulin aspart?
insulin aspart (INSULIN ASPART INJECTION) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for insulin aspart?
INSULIN ASPART INJECTION is a marketed brand name for insulin aspart. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin aspart?
insulin aspart has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.